BROMOCRIPTINE AND ACROMEGALY - THERAPEUTIC IMPLICATIONS

被引：5

作者：

BROOKS, AP

NAIRN, IM

STEPHEN, PJ

STRONG, JA

机构：

[1] Metabolic Unit, University Department of Medicine, Western General Hospital

来源：

JOURNAL OF THE ROYAL SOCIETY OF MEDICINE | 1979年 / 72卷 / 08期

关键词：

D O I：

10.1177/014107687907200804

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：562 / 564

页数：3

共 3 条

[1] DECREASED PLASMA GROWTH-HORMONE (GH) LEVELS IN ACROMEGALICS FOLLOWING CB 154(2-BR-ALPHA-ERGOCRYPTINE) ADMINISTRATION [J].

LIUZZI, A ;

CHIODINI, PG ;

BOTALLA, L ;

CREMASCOLI, G ;

MULLER, EE ;

SILVESTRINI, F .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1974, 38 (05) :910-912

[2] BROMOCRIPTINE TREATMENT OF ACROMEGALY [J].

THORNER, MO ;

CHAIT, A ;

AITKEN, M ;

BENKER, G ;

BLOOM, SR ;

MORTIMER, CH ;

SANDERS, P ;

MASON, AS ;

BESSER, GM .

BRITISH MEDICAL JOURNAL, 1975, 1 (5953) :299-303

[3] LONG-TERM TREATMENT OF ACROMEGALY WITH BROMOCRIPTINE [J].

WASS, JAH ;

THORNER, MO ;

MORRIS, DV ;

REES, LH ;

MASON, AS ;

JONES, AE ;

BESSER, GM .

BRITISH MEDICAL JOURNAL, 1977, 1 (6065) :875-878

← 1 →